Smith I - Search Results

1

HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.

Dowsett M, Harper-Wynne C, Boeddinghaus I, Salter J, Hills M, Dixon M, Ebbs S, Gui G, Sacks N, Smith I. Dowsett M, et al. Among authors: smith i. Cancer Res. 2001 Dec 1;61(23):8452-8. Cancer Res. 2001. PMID: 11731427

2

Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.

Butta A, MacLennan K, Flanders KC, Sacks NP, Smith I, McKinna A, Dowsett M, Wakefield LM, Sporn MB, Baum M, et al. Butta A, et al. Among authors: smith i. Cancer Res. 1992 Aug 1;52(15):4261-4. Cancer Res. 1992. PMID: 1322240

3

Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience.

Dowsett M, Johnston S, Martin LA, Salter J, Hills M, Detre S, Gutierrez MC, Mohsin SK, Shou J, Allred DC, Schiff R, Osborne CK, Smith I. Dowsett M, et al. Among authors: smith i. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S113-7. doi: 10.1677/erc.1.01044. Endocr Relat Cancer. 2005. PMID: 16113087 Review.

4

Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer.

Barton S, Zabaglo L, A'Hern R, Turner N, Ferguson T, O'Neill S, Hills M, Smith I, Dowsett M. Barton S, et al. Among authors: smith i. Br J Cancer. 2012 May 22;106(11):1760-5. doi: 10.1038/bjc.2012.166. Epub 2012 Apr 24. Br J Cancer. 2012. PMID: 22531639 Free PMC article.

5

Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact study.

Yeo B, Zabaglo L, Hills M, Dodson A, Smith I, Dowsett M. Yeo B, et al. Among authors: smith i. Br J Cancer. 2015 Jul 28;113(3):390-5. doi: 10.1038/bjc.2015.222. Epub 2015 Jul 16. Br J Cancer. 2015. PMID: 26180920 Free PMC article.

6

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer.

Ellis P, Smith I, Ashley S, Walsh G, Ebbs S, Baum M, Sacks N, McKinna J. Ellis P, et al. Among authors: smith i. J Clin Oncol. 1998 Jan;16(1):107-14. doi: 10.1200/JCO.1998.16.1.107. J Clin Oncol. 1998. PMID: 9440730

7

Studies of apoptosis in breast cancer.

Parton M, Dowsett M, Smith I. Parton M, et al. Among authors: smith i. BMJ. 2001 Jun 23;322(7301):1528-32. doi: 10.1136/bmj.322.7301.1528. BMJ. 2001. PMID: 11420276 Free PMC article. Review. No abstract available.

8

Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.

Kendall A, Dowsett M, Folkerd E, Smith I. Kendall A, et al. Among authors: smith i. Ann Oncol. 2006 Apr;17(4):584-7. doi: 10.1093/annonc/mdj127. Epub 2006 Jan 27. Ann Oncol. 2006. PMID: 16443612 Free article.

9

Complete excision with narrow margins provides equivalent local control to wider excision in breast conservation for invasive cancer.

Tang SSK, Rapisarda F, Nerurkar A, Osin P, MacNeill F, Smith I, Johnston S, Ross G, Mohammed K, Gui GPH. Tang SSK, et al. Among authors: smith i. BJS Open. 2018 Dec 12;3(2):161-168. doi: 10.1002/bjs5.50121. eCollection 2019 Apr. BJS Open. 2018. PMID: 30957062 Free PMC article.

10

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer.

Modjtahedi H, Hickish T, Nicolson M, Moore J, Styles J, Eccles S, Jackson E, Salter J, Sloane J, Spencer L, Priest K, Smith I, Dean C, Gore M. Modjtahedi H, et al. Among authors: smith i. Br J Cancer. 1996 Jan;73(2):228-35. doi: 10.1038/bjc.1996.40. Br J Cancer. 1996. PMID: 8546911 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,458 results

Search Page

Filters